What top creators are saying about Rocket Lab USA, Inc.(RKLB)— Page 4

Increasingly viewed as a public proxy for SpaceX amid massive inflows into the space sector.

Massive momentum following a $90 million Space Force deal and sector tailwinds from the SpaceX IPO.

Primary way to play the space industry; momentum play that could go vertical.

The dominant public 'Space' play; currently seeing vertical momentum, though analysts suggest taking profits if the vertical move continues.

Experienced a sharp drop; analyst looking for consolidation at lower levels following 'stupid' highs.

Strong momentum leader in space growth, though trading on narrative rather than current profitability.

High euphoria as a SpaceX proxy; parabolic move suggests it may be time to take profits rather than buy.

Identified as a proxy stock experiencing upward momentum ahead of the SpaceX IPO event.

Considered the clear second-best in the space industry; a strategic play on the space narrative before potential SpaceX IPO hype.

Significant weekly gains amid strong momentum.

Experiencing continued gap-up momentum, rising 5.6%.

Trading as a public proxy for SpaceX with strong momentum and progress on the Neutron rocket.

Hit price targets at $120; analyst suggests profit taking as it hits resistance.

Showing strength in the space sector with a 12% price increase.

Experiencing a catchup-trade surge following strong earnings and five major deals.

Showing extreme volatility and growth, attracting momentum traders within the space and defense sector.

Demonstrating 'monster moves' and high volatility, attracting investors looking for crypto-like returns in the space sector.

Announced a partnership with Anduril to develop hypersonic technologies for defense missions, viewed as a positive growth catalyst.

Experiencing weakness as part of a 'risk-off' move in high-beta speculative growth stocks.

Included in a list of bullish US-available stocks.

Has already run up significantly; less favorable trade location than peers.

Benefiting from FOMO in the space sector driven by SpaceX valuation targets.

Primary public proxy for the space sector following the Minarik acquisition and increased defense spending.

Viewed as a high-upside growth stock with multi-bagger potential that can provide life-changing returns through active stock picking.

Part of a massive day for space stocks, rising 12% as investors rotate into space as a growth sector.

Mentioned as a name with strong retail interest and portfolio relevance.

Surged 8-9% on booster tech updates and analyst upgrades, acting as a proxy for SpaceX sentiment.

Targeted for retirement accounts and identified as a brokerage dip buy at $67

Viewed as a proxy for the expanding SpaceX/Starlink ecosystem and space sector growth.

Major number two launch provider with $2.2B backlog, though faces delays with its Neutron rocket development.

Completed Monarch acquisition; needs to clear $79 to signal a run toward $120.

Identified as a primary emerging competitor to SpaceX showing progress in the commercial launch market.

Mentioned as a competitor being outpaced by SpaceX in payload frequency despite high demand for LEO constellations.

Acting as a high-beta proxy for SpaceX; recently raised $474 million via ATM offering.

Strong SpaceX proxy benefiting from satellite launch demand; viewed as a high-beta play with bullish momentum.

Volatile tactical trade; investors are looking to sell into the 'SpaceX pump' hype.

Viewed as the best retail proxy for SpaceX; likely to see a sympathetic rally if SpaceX IPO rumors materialize.

Benefiting from the 'SpaceX Halo Effect' and rising private valuations in the space sector.

Viewed as a high-risk proxy play for space exposure without the high valuation of SpaceX.

Potential beneficiary of NASA outsourcing despite current stock volatility.

Shows strong relative strength by holding ground during market dips; watching for a move over $72.

Included in a tactical $250 initial position with plans for further deployment.

Acquisition of Mirenac in Germany approved; analyst bought more as a favorite space sector play.

Facing significant price pressure as SpaceX launch costs are roughly 12 times lower than Rocket Lab's.

Purchased at an entry price of $57.04 as part of a bullish dip-buying move.

Big move on SpaceX news; facing resistance at 85 with support at 60.

Considered a primary sympathy play and public proxy for the broader space sector and SpaceX.

Included in the group of smaller space stocks described as fundamentally 'shaky'.

Acting as a public proxy for SpaceX IPO excitement, though susceptible to 'sell the news' volatility.

Benefiting from general momentum within the space sector.